Dr. Shivam Om Mittal
MBBS, MD Neurology (UH, Cleveland, USA),
Movement disorders specialist (Mayo Clinic, USA) Diplomate of American Board of Psychiatry and Neurology (ABPN)
Consultant – Neurology


MBBS, MD Neurology (UH, Cleveland, USA),
Movement disorders specialist (Mayo Clinic, USA) Diplomate of American Board of Psychiatry and Neurology (ABPN)
Consultant – Neurology
Total Experience: Over 15 Years
About Dr. Shivam Om Mittal
MD (USA), DSc (Hon), FAAN
Parkinson’s Disease Specialist | Movement Disorders Expert | Neurologist in Abu Dhabi, UAE
Dr. Shivam Om Mittal is an internationally recognized, American board-certified neurologist and an expert in the diagnosis and treatment of Parkinson’s disease, essential tremor, dystonia, and other movement disorders. He is based in Abu Dhabi and serves as the Head of the Parkinson’s Disease and Movement Disorders Center at Cleveland Clinic Abu Dhabi—the first and most advanced multidisciplinary center for movement disorders in the UAE and Gulf region.
Guided by his philosophy of patient-centered care, Dr. Shivam takes personal responsibility for his patients’ health journeys, striving to provide compassionate, evidence-based treatment. He was the first in the GCC to introduce Vyalev (foslevodopa/foscarbidopa) subcutaneous infusion therapy for advanced Parkinson’s disease and has performed over 100 Deep Brain Stimulation (DBS) surgeries in the UAE for Parkinson’s disease, essential tremor, and dystonia—making Cleveland Clinic Abu Dhabi a leading regional referral center.
Dr. Shivam completed his neurology residency at Case Western Reserve University, Cleveland, where he trained under iconic neurologists such as Dr. Robert Daroff (Bradley’s Neurology), Dr. David Preston (EMG), Dr. Bashar Katirji (neuromuscular disorders), Dr. John Leigh (eye movements), and Dr. Hans Lüders (epilepsy). He then pursued a super-specialty fellowship in Movement Disorders at the Mayo Clinic, USA—consistently ranked the No. 1 hospital in neurology—and completed a postdoctoral botulinum toxin fellowship at Yale University. He also holds a Diploma in Clinical Neurology from University College London (UCL) and is pursuing an MBA in Clinical Leadership at the University of Birmingham, UK.
Dr. Shivam has administered botulinum toxin to more than 1,000 patients across a wide spectrum of conditions:
Common disorders: Writer’s cramp, cervical dystonia, hemifacial spasm, blepharospasm, Parkinson’s tremor, sialorrhea, spasticity after stroke
Rare and complex cases: Jaw dystonia, post-radiation focal cancer pain, trigeminal neuralgia, plantar fasciitis, and post-herpetic neuralgia
Dr. Shivam has authored over 40 scientific publications, 35 abstract presentations, and several book chapters. He is the editor of the upcoming Oxford Handbook of Movement Disorders. He received multiple honors including:
Honorary Doctor of Science (DSc) – Datta Meghe Institute, India, 2024
Mount Sinai Award – Case Western, USA, for research excellence
Best Neurologist in Training – AINA, Vancouver, 2016
Junior Investigator Award – Parkinson Study Group, USA
He currently serves in prestigious roles such as:
Executive Committee Member, MDS–Asian & Oceanian Section (MDS-AOS)
Chair, MDS–Middle East Working Group
Board Member, Emirates Neurology Society
Scientific Faculty, MDS International Congress and multiple global symposia
He is regularly invited to speak at top international conferences in Parkinson’s disease, tremor, and advanced therapies, including events in the UAE, India, Japan, Germany, China, and the USA.
Dr. Mittal takes pride in multidisciplinary team approach and works with physiotherapists, occupational therapists, speech therapists, psychiatrists, pain specialists, and nutritionists to offer tailored care. His approach benefits patients not only from Abu Dhabi and Dubai but across the UAE, Gulf countries, and India.
With unwavering commitment to improving lives with Parkinson’s disease, Dr. Shivam Mittal brings together scientific excellence, surgical precision, and compassionate care to help each patient achieve the best possible outcome.